Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the...

New ESC/EAS Focused Update to Guidelines, about how best to manage lipid levels in patients to reduce cardiovascular risk, recommends the use of new...

New ESC Guidelines to improve the diagnosis and care of patients with myocarditis and pericarditis, have been published today at ESC Congress 2025.

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All...

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All...

FRIDAY, Aug. 29, 2025 -- Age is a significant independent risk factor for atrial ectopic burden (AEB) and ventricular ectopic burden (VEB), according...

FRIDAY, Aug. 29, 2025 -- Age is a significant independent risk factor for atrial ectopic burden (AEB) and ventricular ectopic burden (VEB), according...

The European Society of Cardiology (ESC) has released its first Clinical Consensus Statement highlighting the deep, two-way connection between...

TUESDAY, Aug. 26, 2025 -- In a new 2025 joint guideline issued by the American Heart Association and the American College of Cardiology, published...

TUESDAY, Aug. 26, 2025 -- In a new 2025 joint guideline issued by the American Heart Association and the American College of Cardiology, published...